About Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The University of Hong Kong
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The University of Hong Kong
During the past decade, Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The University of Hong Kong conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The University of Hong Kong"
#1 collaborator was "Chinese University of Hong Kong" with 2 trials as a collaborator and "The University of Hong Kong" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The University of Hong Kong
According to Clinical.Site data, the most researched conditions in "Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The University of Hong Kong" are
"Hepatocellular Carcinoma" (2 trials) and "Neoplasm" (2 trials). Many other conditions were trialed in "Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The University of Hong Kong" in a lesser frequency.
Clinical Trials Intervention Types at Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The University of Hong Kong
Most popular intervention types in "Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The University of Hong Kong" are "Biological" (2 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Pegylated Recombinant Human Arginase I" (2 trials) and "Doxorubicin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The University of Hong Kong
The vast majority of trials in "Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The University of Hong Kong" are
2 trials for "All" genders.
Clinical Trials Status at Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The University of Hong Kong
Currently, there are NaN active trials in "Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The University of Hong Kong".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The University of Hong Kong,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The University of Hong Kong, 2 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".